Gritstone Oncology, Inc. (GRTS): Price and Financial Metrics
Gritstone Oncology, Inc. (GRTS)
Today's Latest Price: $5.47 USD
0.63 (-10.33%)
Updated Mar 27 12:00am
Add GRTS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
GRTS Stock Summary
- GRTS's went public 1.5 years ago, making it older than just 1.54% of listed US stocks we're tracking.
- With a price/sales ratio of 51.93, Gritstone Oncology Inc has a higher such ratio than 97.47% of stocks in our set.
- As for revenue growth, note that GRTS's revenue has grown 267.73% over the past 12 months; that beats the revenue growth of 97.62% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Gritstone Oncology Inc are ALPN, XENE, SPRO, PTI, and ARDS.
- GRTS's SEC filings can be seen here. And to visit Gritstone Oncology Inc's official web site, go to www.gritstoneoncology.com.
GRTS Daily Price Range
GRTS 52-Week Price Range
GRTS Stock Price Chart More Charts
GRTS Price/Volume Stats
| Current price | $5.47 | 52-week high | $15.94 |
| Prev. close | $6.10 | 52-week low | $5.44 |
| Day low | $5.46 | Volume | 98,800 |
| Day high | $5.92 | Avg. volume | 159,413 |
| 50-day MA | $8.42 | Dividend yield | N/A |
| 200-day MA | $9.06 | Market Cap | 202.26M |
Gritstone Oncology, Inc. (GRTS) Company Bio
Gritstone Oncology, Inc., an immuno-oncology company, engages in developing personalized cancer immunotherapies for various cancer types in the United States. It is developing GRANITE-001, a personalized immunotherapy product for cancer patients; and SLATE-001 for patients with common tumor neoantigens. The company was founded in 2015 and is based in Emeryville, California.
Loading social stream, please wait...